ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A16AB04 | BioTech | Agalsidase beta - 35mg | 10155 | 118319/1 | FABRAZYME | 35mg | 1 | Injectable powder for concentrate for solution | Infusion | Mersaco | Genzyme Ireland Ltd | Ireland | 295,038,213 L.L | 2.44 | E2 | Genzyme Europe BV | The Netherlands | 12/12/20 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A16AB04 | BioTech | Agalsidase beta - 35mg | 10155/388 | 118319/1 | FABRAZYME | 35mg | 1 | Injectable powder for concentrate for solution | Infusion | Mersaco | Genzyme Ireland Ltd | Ireland | L.L | 2.44 | E2 | Genzyme Europe BV | The Netherlands | 05/02/20 |